🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/10/2002 | 8,15 | 8,28 | 8,01 | 8,15 | -0,91% | 3,25% | 245.400 |
| 01/10/2002 | 8,22 | 8,29 | 8,08 | 8,23 | +0,00% | 2,62% | 321.200 |
| 30/09/2002 | 8,03 | 8,23 | 8,01 | 8,23 | +2,49% | 2,74% | 423.600 |
| 27/09/2002 | 8,25 | 8,28 | 8,02 | 8,03 | -2,73% | 3,15% | 420.600 |
| 26/09/2002 | 8,20 | 8,37 | 7,79 | 8,25 | +0,98% | 7,07% | 408.400 |
| 25/09/2002 | 7,95 | 8,20 | 7,75 | 8,17 | +4,68% | 5,66% | 560.000 |
| 24/09/2002 | 8,03 | 8,05 | 7,52 | 7,81 | -2,38% | 6,66% | 655.200 |
| 23/09/2002 | 8,55 | 8,65 | 8,00 | 8,00 | -6,00% | 7,66% | 719.800 |
| 20/09/2002 | 8,12 | 8,64 | 8,11 | 8,51 | +4,36% | 6,59% | 1.791.000 |
| 19/09/2002 | 8,00 | 8,24 | 8,00 | 8,15 | +1,75% | 3,00% | 436.800 |
| 18/09/2002 | 8,00 | 8,15 | 7,95 | 8,01 | +0,19% | 2,56% | 428.600 |
| 17/09/2002 | 8,09 | 8,22 | 7,95 | 8,00 | -0,87% | 3,28% | 134.600 |
| 16/09/2002 | 8,04 | 8,28 | 7,98 | 8,07 | -2,24% | 3,73% | 303.200 |
| 13/09/2002 | 7,92 | 8,45 | 7,88 | 8,25 | +3,77% | 7,20% | 353.800 |
| 12/09/2002 | 8,20 | 8,20 | 7,88 | 7,95 | -2,87% | 3,96% | 452.400 |
| 11/09/2002 | 8,08 | 8,28 | 8,00 | 8,19 | +2,76% | 3,47% | 327.200 |
| 10/09/2002 | 7,42 | 8,07 | 7,18 | 7,97 | +8,07% | 12,00% | 873.400 |
| 09/09/2002 | 7,42 | 7,43 | 7,26 | 7,37 | -0,81% | 2,29% | 118.200 |
| 06/09/2002 | 7,15 | 7,46 | 7,14 | 7,43 | +5,39% | 4,41% | 135.200 |
| 05/09/2002 | 7,33 | 7,45 | 7,03 | 7,05 | -3,89% | 5,73% | 435.000 |
| 04/09/2002 | 7,02 | 7,40 | 6,93 | 7,34 | +5,62% | 6,62% | 136.000 |
| 03/09/2002 | 7,35 | 7,38 | 6,95 | 6,95 | -5,51% | 5,92% | 257.000 |
| 30/08/2002 | 7,43 | 7,50 | 7,35 | 7,35 | +0,00% | 2,02% | 192.400 |
| 29/08/2002 | 7,22 | 7,52 | 7,16 | 7,35 | +3,23% | 4,92% | 207.200 |
| 28/08/2002 | 7,15 | 7,48 | 7,12 | 7,12 | +0,35% | 5,03% | 275.200 |
| 27/08/2002 | 7,23 | 7,33 | 7,08 | 7,10 | -0,98% | 3,46% | 449.000 |
| 26/08/2002 | 7,03 | 7,25 | 6,57 | 7,17 | +2,43% | 9,75% | 599.000 |
| 23/08/2002 | 6,98 | 7,12 | 6,79 | 7,00 | -0,43% | 4,73% | 290.400 |
| 22/08/2002 | 7,25 | 7,25 | 7,00 | 7,03 | -1,33% | 3,45% | 418.200 |
| 21/08/2002 | 6,80 | 7,27 | 6,70 | 7,12 | +4,71% | 8,31% | 80.400 |